Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market Size, Epidemiology, Therapies, Drugs and Key Companies by DelveInsight

DelveInsight's "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC), historical and forecasted epidemiology as well as the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some facts of Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market:

·         The highest number of NSCLC Cases were estimated in the United States.

·         According to DelveInsight's assessment, in the United States, 7 out of 10 patients had metastatic NSCLC (Stage IIIb and IV).

·         The United States had 227,875 incident cases of Lung Cancer in 2020, of which ~85% were NSCLC cancer patient (GLOBOCAN, n.d..)

·         Among the European 5 countries, the Germany had highest cases of NSCLC. Furthermore, Japan accounts for about 117,752 cases in 2020.

·         DelveInsight’s analysts have estimated that in 2020, in the United States there were over 38,000 incident cases for EGFR mutation.

Request for Sample Report: https://www.delveinsight.com/sample-request/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market

View Report: https://www.delveinsight.com/report-store/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market

Scope of the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Market  Report

·         The report covers the descriptive overview of Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

·         Comprehensive insight has been provided into the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) epidemiology and treatment in the 7MM

·         Additionally, an all-inclusive account of both the current and emerging therapies for Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

·         A detailed review of the Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) market; historical and forecasted is included in the report, covering drug outreach in the 7MM

·         The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) market

NSCLC is the most common type of lung cancer and metastasizes to other organs slower in comparison to SCLC, and microscopically, SCLC is composed of much smaller cells. Recent advances in understanding of cell signalling pathways that control cell survival have identified genetic and regulatory aberrations that suppress cell death, promote cell division, and induce tumorogenesis. One such discovery is that of epidermal growth factor receptor (EGFR). EGFR is a transmembrane receptor tyrosine kinase protein that is expressed in some normal epithelial, mesenchymal, and neurogenic tissue. Overexpression of EGFR has been reported and implicated in the pathogenesis of many human malignancies, including NSCLC. The EGFR gene may also undergo amplification, as detected by fluorescence in situ hybridization (FISH) or chromogenic in situ hybridization (CISH).

Request for Sample Report: https://www.delveinsight.com/sample-request/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market

View Report: https://www.delveinsight.com/report-store/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market

Some of Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Companies are:

·         Takeda

·         Yuhan Corporation

·         Janssen Research & Development

·         Novartis

·         Daiichi Sankyo

·         Astellas

·         Astrazeneca

·         And Many Others

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Therapies covered:

·         TAK-788 (mobocertinib)

·         Lazertinib (Leclaza)

·         Nazartinib (EGF816)

·         Patritumab deruxtecan (HER3-DXd)

·         And Many Others

Request for Sample Report: https://www.delveinsight.com/sample-request/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market

View Report: https://www.delveinsight.com/report-store/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market

Table of Contents:

1. Key Insights

2. Executive Summary of Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)

3. Competitive Intelligence Analysis for Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)

4. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC): Market Overview at a Glance

5. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC): Disease Background and Overview

6. Patient Journey

7. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Unmet Needs

10. Key Endpoints of Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Treatment

11. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Marketed Products

List to be continued in report

12. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) Emerging Therapies

13. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Other Reports:

Related Blogs:

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Ankit Nigam

Email: info@delveinsight.com

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more